Srinivas Vourganti to Transplantation, Heterologous
This is a "connection" page, showing publications Srinivas Vourganti has written about Transplantation, Heterologous.
Connection Strength
0.028
-
Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder. J Natl Cancer Inst. 2004 Oct 06; 96(19):1447-57.
Score: 0.015
-
GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder. J Clin Invest. 2001 Sep; 108(6):887-94.
Score: 0.012